These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11782706)

  • 1. [State of the art and therapeutic prospects in neuroectodermal tumours and other neuroendocrine pathologies].
    Guida T; Belsito Petrizzi V; Fiorentino R; Germano D; Guardasi R; Lentini-Graziano ML; Cartenì G
    Minerva Endocrinol; 2001 Dec; 26(4):215-24. PubMed ID: 11782706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
    Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
    Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives in the treatment of neuroendocrine tumours.
    Bajetta E; Catena L; Valente M; Bianco N; Bellomo F; Bombardieri E
    Anticancer Res; 2012 Oct; 32(10):4193-200. PubMed ID: 23060539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current medical treatment of pancreatic neuroendocrine tumors.
    Yalcin S; Oyan B; Bayraktar Y
    Hepatogastroenterology; 2007; 54(73):278-84. PubMed ID: 17419276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.
    Srirajaskanthan R; Toumpanakis C; Meyer T; Caplin ME
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1143-54. PubMed ID: 19298583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the treatment of neuroendocrine tumors.
    Bajetta E; Procopio G; Ferrari L; Catena L; Del Vecchio M; Bombardieri E
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):631-42. PubMed ID: 14599087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogs for the treatment of neuroendocrine tumors.
    Culler MD; Oberg K; Arnold R; Krenning EP; Sevilla I; Díaz JA
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():9-17. PubMed ID: 21369878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine tumours of the gastrointestinal tract].
    Plöckinger U; Wiedenmann B
    Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of neuroendocrine tumours: current and future medical therapy options.
    Oberg KE
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):282-93. PubMed ID: 21907552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
    Grozinsky-Glasberg S; Shimon I; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2008 Sep; 15(3):701-20. PubMed ID: 18524947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
    Oberg K
    Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
    Khan MS; Caplin ME
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumours.
    Hodolic M; Fettich J; Marzola MC; Tonini E; Al-Nahhas A; Rubello D
    In Vivo; 2010; 24(1):97-100. PubMed ID: 20133983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art and future prospects in the management of neuroendocrine tumors.
    Oberg K
    Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.